Phase II study of dutasteride in prostate cancer recurrent during androgen deprivation therapy.
Phase of Trial: Phase II
Latest Information Update: 30 Apr 2013
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Mar 2007 New trial record.